Fatty acid metabolism in obesity and type 2 diabetes mellitus

Proceedings of the Nutrition Society

Volumn 62, Issue 3, 2003, Pages 753-760

  Blaak, E E ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Fatty acid metabolism; Obesity; Type 2 diabetes mellitus

Indexed keywords

CATECHOLAMINE; FATTY ACID; INSULIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; CONFERENCE PAPER; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; HUMAN; INSULIN RESISTANCE; LIPID STORAGE; LIPOLYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SKELETAL MUSCLE; TISSUE PRESERVATION;

DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; FATTY ACIDS, NONESTERIFIED; HUMANS; LIPOLYSIS; MUSCLE, SKELETAL; OBESITY;

EID: 0141857891     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS2003290     Document Type: Conference Paper

References (71)

1. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW & Scott J (1999) Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nature Genetics 21, 76-83.
2. Astrup A, Buemann B, Toubro S & Raben A (1996) Defects in substrate oxidation involved in the predisposition to obesity. Proceedings of the Nutrition Society 55, 817-828.
3. Blaak EE, Glatz JF & Saris WH (2001a) Increase in skeletal muscle fatty acid binding protein (FABPC) content is directly related to weight loss and to changes in fat oxidation following a very low calorie diet. Diabetologia 44, 2013-2177.
4. Blaak EE, van Aggel-Leijssen DP, Wagenmakers AJ, Saris WH & van Baak MA (2000a) Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes 49, 2102-2107.
5. Blaak EE, Van Baak MA, Kemerink GJ, Pakbiers MT, Heidendal GA & Saris WH (1994a) Beta-adrenergic stimulation of energy expenditure and forearm skeletal muscle metabolism in lean and obese men. American Journal of Physiology 267, E306-E315.
6. Blaak EE, Van Baak MA, Kemerink GJ, Pakbiers MT, Heidendal GA & WH Saris GA (1994b) beta-Adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men. American Journal of Physiology 267, E316-E322.
7. Blaak EE, Wagenmakers AJ, Glatz JF, Wolffenbuttel BH, Kemerink GJ, Langenberg CJ, Heidendal GA & Saris WH (2000b) Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. American Journal of Physiology 279, E146-E154.
8. Blaak EE, Wolffenbuttel BH, Saris WH, Pelsers MM & Wagenmakers AJ (2001b) Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects. Journal of Clinical Endocrinology and Metabolism 86, 1638-1644.
9. Boden G (1999) Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Proceedings of the Association of American Physicians 111, 241-248.
10. Clifford GM, Londos C, Kraemer FB, Vernon RG & Yeaman SJ (2000) Translocation of hormone-sensitive lipase and perilipin upon lipolytic stimulation of rat adipocytes. Journal of Biological Chemistry 275, 5011-5015.
11. Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL & Abumrad NA (2000) Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. Journal of Biological Chemistry 275, 32523-32529.
12. Colberg SR, Simoneau JA, Thaete FL & Kelley DE (1995) Skeletal muscle utilization of free fatty acids in women with visceral obesity. Journal of Clinical Investigation 95, 1846-1853.
13. Connacher AA, Bennet WM, Jung RT, Bier DM, Smith CC, Scrimgeour CM & Rennie MJ (1991) Effect of adrenaline infusion on fatty acid and glucose turnover in lean and obese human subjects in the post-absorptive and fed states. Clinical Science 81, 635-644.
14. Ellis BA, Poynten A, Lowy AJ, Furler SM, Chisholm DJ, Kraegen EW & Cooney GJ (2000) Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. American Journal of Physiology 279, E554-E560.
15. Enoksson S, Degerman E, Hagstrom-Toft E, Large V & Amer P (1998) Various phosphodiesterase subtypes mediate the in vivo antilipolytic effect of insulin on adipose tissue and skeletal muscle in man. Diabetologia 41, 560-568.
16. Ezell DM, Geiselman PJ, Anderson AM, Dowdy ML, Womble LG, Greenway FL & Zachwieja JJ (1999) Substrate oxidation and availability during acute exercise in non-obese, obese, and post-obese sedentary females. International Journal of Obesity and Related Disorders 23, 1047-1056.
17. Frayn KN, Williams CM & Amer P (1996) Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? Clinical Science 90, 243-253.
18. Froidevaux F, Schutz Y, Christin L & Jequier E (1993) Energy expenditure in obese women before and during weight loss, after refeeding, and in the weight-relapse period. American Journal of Clinical Nutrition 57, 35-42.
19. Geerling BJ, Alles MS, Murgatroyd PR, Goldberg GR, Harding M & Prentice AM (1994) Fatness in relation to substrate oxidation during exercise. International Journal of Obesity and Related Disorders 18, 453-459.
20. Glatz JF, Luiken JJ & Bonen A (2001a) Involvement of membrane-associated proteins in the acute regulation of cellular fatty acid uptake. Journal of Molecular Neuroscience 16, 123-132.
21. Glatz JF, Luiken JJ & Bonen A (2001b) Involvement of membrane-associated proteins in the acute regulation of cellular fatty acid uptake (Discussion). Journal of Molecular Neuroscience 16, 151-157.
22. Hagstrom-Toft E, Thorne A, Reynisdottir S, Moberg E, Rossner S, Bolinder J & Arner P (2001) Evidence for a major role of skeletal muscle lipolysis in the regulation of lipid oxidation during caloric restriction in vivo. Diabetes 50, 1604-1611.
23. Hajri T, Ibrahimi A, Coburn CT, Knapp FF Jr, Kurtz T, Pravenec M & Abumrad NA (2001) Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. Journal of Biological Chemistry 276, 23661-23666.
24. He J, Watkins S & Kelley DE (2001) Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 50, 817-823.
25. Helge JW, AM Fraser, AD Kriketos, AB Jenkins, GD Calvert, KJ Ayre & LH Storlien (1999) Interrelationships between muscle fibre type, substrate oxidation and body fat. International Journal of Obesity and Related Disorders 23, 986-991.
26. Hellstrom L, Langin D, Reynisdottir S, Dauzats M & Arner P (1996) Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives. Diabetologia 39, 921-928.
27. Hennes MM, Dua A & Kissebah AH (1997) Effects of free fatty acids and glucose on splanchnic insulin dynamics. Diabetes 46, 57-62.
28. Holm C, Osterlund T, Laurell H & Contreras JA (2000) Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annual Review of Nutrition 20, 365-393.
29. Horowitz JF & Klein S (2000) Oxidation of nonplasma fatty acids during exercise is increased in women with abdominal obesity. Journal of Applied Physiology 89, 2276-2282.
30. Ishiyama-Shigemoto S, Yamada K, Yuan X, Ichikawa F & Nonaka K (1999) Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 42, 98-101.
31. Itani SI, Ruderman NB, Schmieder F & Boden G (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51, 2005-2011.
32. Jensen MD, Haymond MW, Rizza RA, Cryer PE & Miles JM (1989) Influence of body fat distribution on free fatty acid metabolism in obesity. Journal of Clinical Investigation 83, 1168-1173.
33. Kelley DE, Goodpaster B, Wing RR & Simoneau JA (1999) Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. American Journal of Physiology 277, E1130-E1141.
34. Kelley DE & Mandarino LJ (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49, 677-683.
35. Kelley DE & Simoneau JA (1994) Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation 94, 2349-2356.
36. Kempen KP, Saris WH, Kuipers H, Glatz JF & Van Der Vusse GJ (1998) Skeletal muscle metabolic characteristics before and after energy restriction in human obesity: fibre type, enzymatic beta-oxidative capacity and fatty acid-binding protein content. European Journal of Clinical Investigation 28, 1030-1037.
37. Kim JY, Hickner RC, Cortright RL, Dohm GL & Houmard JA (2000) Lipid oxidation is reduced in obese human skeletal muscle. American Journal of Physiology 279, E1039-E1044.
38. Klannemark M, Orho M, Langin D, Laurell H, Holm C, Reynisdottir S, Arner P & Groop L (1998) The putative role of the hormone-sensitive lipase gene in the pathogenesis of Type II diabetes mellitus and abdominal obesity. Diabetologia 41, 1516-1522.
39. Langfort J, Ploug T, Ihlemann J, Enevoldsen LH, Stallknecht B, Saldo M, Kjaer M, Holm C & Galbo H (1998) Hormone-sensitive lipase (HSL) expression and regulation in skeletal muscle. Advances in Experimental Medicine and Biology 441, 219-228.
40. Langfort J, Ploug T, Ihlemann J, Saldo M, Holm C & Galbo H (1999) Expression of hormone-sensitive lipase and its regulation by adrenaline in skeletal muscle. Biochemical Journal 340, 459-465.
41. Large V, Hellstrom L, Reynisdottir S, Lonnqvist F, Eriksson P, Lannfelt L & Arner P (1997) Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associated with altered adipocyte beta-2 adrenoceptor function. Journal of Clinical Investigation 100, 3005-3013.
42. Levin K, Daa Schroeder H, Alford FP & Beck-Nielsen H (2001) Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes. Diabetologia 44, 824-833.
43. Magre J, Laurell H, Fizames C, Antoine PJ, Dib C, Vigouroux C, Bourut C, Capeau J, Weissenbach J & Langin D (1998) Human hormone-sensitive lipase: genetic mapping, identification of a new dinucleotide repeat, and association with obesity and NIDDM. Diabetes 47, 284-286.
44. Malenfant P, Tremblay A, Doucet E, Imbeault P, Simoneau JA & Joanisse DR (2001) Elevated intramyocellular lipid concentration in obese subjects is not reduced after diet and exercise training. American Journal of Physiology 280, E632-E639.
45. Mandarino LJ, Consoli A, Jain A & Kelley DE (1996) Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. American Journal of Physiology 270, FA63-FA670.
46. Meirhaeghe A, Helbecque N, Cottel D & Amouyel P (2000) Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population. International Journal of Obesity and Related Disorders 24, 382-387.
47. Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ & Saris WH (2001) Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 50, 2548-2554.
48. Miyaoka K, Kuwasako T, Hirano K, Nozaki S, Yamashita S & Matsuzawa Y (2001) CD36 deficiency associated with insulin resistance. Lancet 357, 686-687.
49. Nozaki S, Tanaka T, Yamashita S, Sohmiya K, Yoshizumi T, Okamoto F, Kitaura Y, Kotake C, Nishida H, Nakata A, Nakagawa T, Matsumoto K, Kameda-Takemura K, Tadokoro S, Kurata Y, Tomiyama Y, Kawamura K & Matsuzawa Y (1999) CD36 mediates long-chain fatty acid transport in human myocardium: complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency. Molecular and Cellular Biochemistry 192, 129-135.
50. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB & Storlien LH (1997) Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46, 983-938.
51. Pelsers MM, Lutgerink JT, Nieuwenhoven FA, Tandon NN, van der Vusse GJ, Arends JW, Hoogenboom HR & Glatz JF (1999) A sensitive immunoassay for rat fatty acid translocase (CD36) using phage antibodies selected on cell transfectants: abundant presence of fatty acid translocase/CD36 in cardiac and red skeletal muscle and up-regulation in diabetes. Biochemical Journal 337, 407-414.
52. Pihlajamaki J, Valve R, Karjalainen L, Karhapaa P, Vauhkonen I & Laakso M (2001) The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance. European Journal of Clinical Investigation 31, 302-308.
53. Pravenec M, Landa V, Zidek V, Musilova A, Kren V, Kazdova L, Aitman TJ, Glazier AM, Ibrahimi A, Abumrad NA, Qi N, Wang JM, St Lezin EM & Kurtz TW (2001) Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nature Genetics 27, 156-158.
54. Prentki M & Corkey BE (1996) Are β-cell signalling molecules malonyl CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM. Diabetes 45, 273-283.
55. Randle PJ (1998) Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metabolism Reviews 14, 263-283.
56. Ranneries C, Bulow J, Buemann B, Christensen NJ, Madsen J & Astrup A (1998) Fat metabolism in formerly obese women. American Journal of Physiology 274, E155-E161.
57. Reynisdottir S, Ellerfeldt K, Wahrenberg H, Lithell H & Arner P (1994) Multiple lipolysis defects in the insulin resistance (metabolic) syndrome. Journal of Clinical Investigation 93, 2590-2599.
58. Reynisdottir S, Langin D, Carlstrom K, Holm C, Rossner S & Amer P (1995) Effects of weight reduction on the regulation of lipolysis in adipocytes of women with upper-body obesity. Clinical Science 89, 421-429.
59. Roden M, Krssak M, Stingl H, Gruber S, Hofer A, Fumsinn C, Moser E & Waldhausl W (1999) Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes 48, 358-364.
60. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW & Shulman GI (1996) Mechanism of free fatty acid-induced insulin resistance in humans. Journal of Clinical Investigation 97, 2859-2865.
61. Saha AK, Vavvas D, Kurowski TG, Apazidis A, Witters LA, Shafrir E & Ruderman NB (1997) Malonyl-CoA regulation in skeletal muscle: its link to cell citrate and the glucose-fatty acid cycle. American Journal of Physiology 272, E641-E648.
62. Schiffelers SL, Saris WH, Boomsma F & van Baak MA (2001) beta(1)- and beta(2)-Adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men. Journal of Clinical Endocrinology and Metabolism 86, 2191-2199.
63. Simoneau JA, Colberg SR, Thaete FL & Kelley DE (1995) Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB Journal 9, 273-278.
64. Simoneau JA, Veerkamp JH, Turcotte LP & Kelley DE (1999) Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB Journal 13, 2051-2060.
65. Souza SC, de Vargas LM, Yamamoto MT, Lien P, Franciosa MD, Moss LG & Greenberg AS (1998) Overexpression of perilipin A and B blocks the ability of tumor necrosis factor alpha to increase lipolysis in 3T3-L1 adipocytes. Journal of Biological Chemistry 273, 24665-24669.
66. Svedberg J, Bjorntorp P, Smith U & Lonnroth P (1990) Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 39, 570-574.
67. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V & Uusitupa M, for the Finnish Diabetes Prevention Study Group (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine 344, 1343-1350.
68. Ukkola O, Rankinen T, Weisnagel SJ, Sun G, Perusse L, Chagnon YC, Despres JP & Bouchard C (2000) Interactions among the alpha2-, beta2-, and beta3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study. Metabolism 49, 1063-1070.
69. van der Vusse GJ, van Bilsen M, Glatz JF, Hasselbaink DM & Luiken JJ (2002) Critical steps in cellular fatty acid uptake and utilization. Molecular and Cellular Biochemistry 239, 9-15.
70. Wade AJ, Marbut MM & Round JM (1990) Muscle fibre type and aetiology of obesity. Lancet 335, 805-808.
71. Zurlo F, Lillioja S, Esposito-Del Puente A, Nyomba BL, Raz I, Saad MF, Swinbum BA, Knowler WC, Bogardus C & Ravussin E (1990) Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. American Journal of Physiology 259, E650-E657.